Symrise AG (ETR:SY1)
Germany
· Delayed Price · Currency is EUR | Market Cap | 10.81B |
| Revenue (ttm) | 4.99B |
| Net Income (ttm) | 506.93M |
| Shares Out | 139.30M |
| EPS (ttm) | 3.63 |
| PE Ratio | 21.36 |
| Forward PE | 20.55 |
| Dividend | 1.20 (1.57%) |
| Ex-Dividend Date | May 21, 2025 |
| Volume | 917,162 |
| Average Volume | 468,586 |
| Open | 76.50 |
| Previous Close | 76.60 |
| Day's Range | 76.08 - 78.06 |
| 52-Week Range | 64.70 - 107.20 |
| Beta | 0.56 |
| RSI | 61.55 |
| Earnings Date | Mar 4, 2026 |
About Symrise AG
Symrise AG operates as a supplier of fragrances, flavorings, cosmetic base materials and active ingredients, and functional ingredients and solutions in Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America. The company operates in two segments, Taste, Nutrition & Health; and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and product solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, ba... [Read more]
Financial Performance
In 2024, Symrise AG's revenue was 5.00 billion, an increase of 5.67% compared to the previous year's 4.73 billion. Earnings were 478.22 million, an increase of 40.46%.
Financial StatementsNews
EQS-DD: Symrise AG: Dr. Stephanie Coßmann, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 12.02.2026 / 15:34 CET/CEST The issuer is solely responsi...
Oakmark International Strategy Q4 2025 New Investments And Divestments
Oakmark International Strategy Q4 2025 New Investments And Divestments
DAX Recovers After Early Setback; Brenntag, Symrise Rise Sharply
BRUSSELS (dpa-AFX) - German stocks turned in a mixed performance Wednesday morning with investors assessing the latest sect of economic data from the region, and earnings updates, while awaiting t...
EQS-CMS: Symrise AG: Release of a capital market information
EQS Post-admission Duties announcement: Symrise AG / Announcement pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052 Symrise AG...
Harding Loevner International Equity ADR Q3 2025 Portfolio Update
The International Equity ADR composite rose 3.0% gross of fees in the second quarter, behind the 7.0% gain of the MSCI ACWI ex US Index. In Communication Services, Tencent delivered a second consecuti...
Symrise and Aplantex Confirm an Agreement to Establish a Partnership
MONTREAL--(BUSINESS WIRE)--Symrise AG ("Symrise") and Aplantex Bio ("Aplantex") agree on a partnership covering new technologies for accessing plant-based molecules as raw material once the molecules ...
The Moat Might Be Narrow, But Symrise Looks Undervalued (Rating Upgrade)
Symrise AG is now rated a 'Buy' as the stock trades below intrinsic value after a 30% decline from previous coverage. Despite recent sales declines due to FX headwinds, SYIEF demonstrated organic grow...
Symrise AG (SYIEF) H1 2025 Earnings Call Transcript
Symrise AG (OTCPK:SYIEF) H1 2025 Earnings Call July 30, 2025 5:00 AM ET Company Participants Jean-Yves Parisot - CEO, Head of Scent & Care and Member of Executive Board Olaf Klinger - CFO, Head of Fin...
Hofseth Biocare ASA: HBC ACCELERATES IN HUMAN HEALTH AND PET NUTRITION THROUGH A STRATEGIC PARTNERSHIP WITH SYMRISE TO BUILD OUT BERKÅK, TRIPLING THE MANUFACTURING CAPACITY OF THE GROUP
HBC will accelerate its manufacturing scale and market reach with the construction of a second enzymatic hydrolysis plant in Berkåk, Norway. Symrise will support the financing of the project through a...
Symrise AG (SYIEF) Q3 2024 Earnings Call Transcript
Symrise AG (OTCPK:SYIEF) Q3 2024 Earnings Conference Call October 24, 2024 2:00 AM ET Company Participants Jean-Yves Parisot - President, Taste Nutrition & Health & Incoming CEO Olaf Klinger - CFO Con...
Symrise AG (SYIEF) Q2 2024 Earnings Call Transcript
Start Time: 05:00 January 1, 0000 6:03 AM ET Symrise AG (OTCPK:SYIEF) Q2 2024 Earnings Conference Call August 01, 2024, 05:00 AM ET Company Participants Olaf Klinger - Chief Financial Officer Jean-Yve...
Symrise AG (SYIEF) Q4 2023 Earnings Call Transcript
Symrise AG (OTCPK:SYIEF) Q4 2023 Earnings Conference Call March 6, 2024 7:00 AM ET Company Participants Tobias Erfurth - Head, Investor Relations Heinz-Jurgen Bertram - Chief Executive Officer Olaf Kl...
European Dividend Gems: Symrise AG
Symrise is one of the top players in the highly concentrated aroma molecules, flavours, and fragrances market. Ingredients from this company are used in products we use on a daily basis, resulting in ...
Symrise AG (SYIEF) Q4 2022 Earnings Call Transcript
Symrise AG (OTCPK:SYIEF) Q4 2022 Earnings Conference Call March 8, 2023 7:00 AM ET Company Participants Tobias Erfurth - Head, IR Heinz-Jurgen Bertram - CEO Stephanie Cossmann - Human Resources and Le...
Symrise AG (SYIEF) CEO Dr. Heinz-Jürgen Bertram on Q4 2021 Results - Earnings Call Transcript
Symrise AG (SYIEF) CEO Dr. Heinz-Jürgen Bertram on Q4 2021 Results - Earnings Call Transcript
Symrise AG (SYIEF) CEO Heinz-Jürgen Bertram on Q2 2021 Results - Earnings Call Transcript
Symrise AG (SYIEF) CEO Heinz-Jürgen Bertram on Q2 2021 Results - Earnings Call Transcript
Symrise AG (SYIEF) CEO Heinz-Jürgen Bertram on 2020 Financial Results - Earnings Call Transcript
Symrise AG (SYIEF) CEO Heinz-Jürgen Bertram on 2020 Financial Results - Earnings Call Transcript
Hidden Stock Market Gems: Symrise
Symrise was founded in 2003 in Holzminden and is providing flavor and fragrance experiences for food production.